Filed Pursuant to Rule 424(b)(2)
Registration No. 333-278934
PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED MAY 31, 2024
UBS AG
Senior Debt Securities
We may offer from time to time our senior debt securities (collectively, the “notes”), directly or through any one of our branches.
The notes will bear interest, if any, at either a fixed or a floating rate. Interest will be paid on the dates stated in the applicable pricing supplement. The notes may be either callable by us or puttable by you, if specified in the applicable pricing supplement. The specific terms of each note offered will be described in the applicable pricing supplement, and the terms may differ from those described in this prospectus supplement.
On December 7, 2023, UBS AG and Credit Suisse AG (“CS AG”) entered into a merger agreement (as such agreement may be amended from time to time, the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, UBS AG and CS AG agreed to a merger by absorption under Swiss law (Absorptionsfusion) whereby CS AG (including its branches) would be absorbed by UBS AG (the “Merger”), and effective upon registration of the Merger with the Commercial Registers of the Canton of Zurich and the Canton of Basel-City in Switzerland, CS AG would cease to exist and all of its assets, liabilities and contracts would automatically transfer to, and be absorbed and taken over by, UBS AG by operation of Swiss law (Universalsukzession). The Merger was completed on May 31, 2024. In connection with the Merger, on May 30, 2024, UBS AG, CS AG and The Bank of New York Mellon (formerly known as The Bank of New York), as trustee (the “Trustee”), entered into a fourth supplemental indenture (the “Fourth Supplemental Indenture”) to the senior indenture between CS AG and the Trustee dated as of March 29, 2007 (as supplemented, the “Senior Indenture”). Pursuant to the Fourth Supplemental Indenture and effective upon completion of the Merger and by operation of Swiss law, UBS AG expressly assumed all of CS AG’s obligations, and succeeded to all of CS AG’s rights, under the Senior Indenture and all outstanding and future notes issued thereunder. The notes offered by this prospectus supplement will be issued by UBS AG under the Senior Indenture or will have been previously issued by CS AG (now UBS AG) under the Senior Indenture and may be the subject of ongoing market-making transactions as described in this prospectus supplement.
Investing in the notes involves risks. See the risk factors set out under “Risk Factors” in Part I, Item 3D of the UBS 2023 20-F (as defined below) and the risk factors we describe on page S-1 of this prospectus supplement and any additional risk factors we describe in future filings we make with the Securities and Exchange Commission (the “SEC”) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are incorporated by reference herein. Unless the context otherwise requires and except as otherwise indicated, in this prospectus supplement, the terms “we,” “our,” and “us” refer to UBS AG on a parent only basis. “UBS” or the “Group” refers to UBS Group AG and its consolidated subsidiaries.
Unless otherwise provided in the applicable pricing supplement, we will sell the notes to the public at 100% of their principal amount. Unless otherwise provided in the applicable pricing supplement, we will receive between 99.875% and 99.250% of the proceeds from the sale of the notes, after paying the commissions or discounts of the Distributors (as defined herein) of between 0.125% and 0.750% for the notes; provided that, commissions with respect to notes with a stated maturity of more than thirty years from the date of issue will be negotiated at the time of sale.
The notes may be offered directly or to or through underwriters, agents or dealers, including UBS Securities LLC, UBS Financial Services Inc., Credit Suisse Securities (USA) LLC, or any other subsidiary or affiliate of UBS AG. Because of this relationship, UBS Securities LLC, UBS Financial Services Inc., and Credit Suisse Securities (USA) LLC would have a “conflict of interest” within the meaning of Rule 5121 of the Financial Industry Regulatory Authority, Inc. (“FINRA”). If UBS Securities LLC, UBS Financial Services Inc., Credit Suisse Securities (USA) LLC, or our other U.S.-registered broker-dealer subsidiaries or affiliates participate in the distribution of our securities, we will conduct the offering in accordance with the applicable provisions of FINRA Rule 5121. See “Plan of Distribution (Conflicts of Interest).”
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these notes or passed upon the adequacy or accuracy of this prospectus supplement or any accompanying prospectus or pricing supplement. Any representation to the contrary is a criminal offense.
The notes are not deposit liabilities and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction. Unless otherwise provided in the applicable pricing supplement, the notes will not have the benefit of any agency or governmental guarantee.
This prospectus supplement may be used by UBS Securities LLC, UBS Financial Services Inc., Credit Suisse Securities (USA) LLC or any other affiliate of UBS AG in connection with offers and sales in market-making transactions of notes issued under the Senior Indenture. In a market-making transaction, UBS Securities LLC, UBS Financial Services Inc., Credit Suisse Securities (USA) LLC or any other affiliate of UBS AG may resell notes it acquires from other holders, after the original offering and sale of the note. Resales of this kind may occur in the open market or may be privately negotiated at prevailing market prices at the time of resale or at related or negotiated prices. In these transactions, UBS Securities LLC, UBS Financial Services Inc., Credit Suisse Securities (USA) LLC or any other affiliate of UBS AG may act as principal or agent, including as agent for the counterparty in a transaction in which it acts as principal, or as agent for both counterparties in a transaction in which it does not act as principal. UBS Securities LLC, UBS Financial Services Inc., Credit Suisse Securities (USA) LLC or any other affiliate of UBS AG may receive compensation in the form of discounts and commissions, including from both counterparties in some cases..
UBS AG
The date of this prospectus supplement is May 31, 2024.